U.S. flag

An official website of the United States government, Department of Justice.

NCJRS Virtual Library

The Virtual Library houses over 235,000 criminal justice resources, including all known OJP works.
Click here to search the NCJRS Virtual Library

Prescription Drug Monitoring Program: Wisconsin State Profile

NCJ Number
Date Published
October 2018
8 pages
Information and data are presented for the Wisconsin Prescription Drug Monitoring Program (WI PDMP), which is administered by the Wisconsin Controlled Substances Board, a state professional licensing agency.
The PDMP's email address is provided, along with website addresses for the home page, enrollment, queries, data upload, and statistics. Contact information is provided for the Managing Director and the Deputy Director. Statistics for 2017 cover the state population (5,818,049), DEA registered prescribers (32,096), and DEA registered dispensers (1,222). Nineteen available PDMP reports are listed. PDMP was funded in 2018 by licensing fees. PDMP staff numbers for 2018 are provided for the following job categories: operational (3), technical (0), analytical (1), and "other" (0). Key dates in PDMP's development pertain to enabling legislation (May 2010), becoming operational (April 2013), initial user access (June 2013), on-line access (June 2013), and electronic reporting (April 2013). Source information is provided for Wisconsin statutes and rules relevant to PDMP's policies and procedures. Data on monitored drugs must be reported the next business day after their prescribing, and zero reporting is required. Monitored drugs are controlled substances in schedules II, III, IV, and V. Information is also required on opioid-related drug overdoses or deaths, patient lock-in information, lost/stolen prescription drug reports, and arrest/conviction data. Nine miscellaneous capabilities and policies are listed. Enrollment in the PDMP is not required for either prescribers or dispensers, but prescribers, although not dispensers, are required to use it. Law enforcement personnel who seek data on patient drug use must have an active investigation that involves particular patients. There is no data retention policy. No requestor training is required or available. Technological capabilities of the PDMP data system are reported, along with reports authorized and that have been produced by requestor type.